Pfizer CSO Mikael Dolsten at #JPM24 (Brian Benton Photography)
July 9, 2024 07:29 AM EDTUpdated 08:50 AM
People

Pfiz­er CSO Mikael Dol­sten to de­part af­ter 15 years lead­ing drug gi­ant's R&D

Kyle LaHucik

Senior Reporter

Mikael Dol­sten, a long­time leader of drug R&D at one of the world’s biggest phar­ma gi­ants, will de­part his post as chief sci­en­tif­ic of­fi­cer at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times